A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia
Related Articles
- Is the PANSS used correctly? a systematic review. Obermeier, Michael; Schennach-Wolff, Rebecca; Meyer, Sebastian; Möller, Hans-Jürgen; Riedel, Michael; Krause, Daniela; Seemüller, Florian // BMC Psychiatry;2011, Vol. 11 Issue 1, p113
Background: The PANSS (Positive and Negative Syndrome Scale) is one of the most important rating instruments for patients with schizophrenia. Nevertheless, there is a long and ongoing debate in the psychiatric community regarding its mathematical properties. All 30 items range from 1 to 7...
- Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis. Turkoz, Ibrahim; Bossie, Cynthia A.; Lindenmayer, Jean-Pierre; Schooler, Nina; Canuso, Carla M. // BMC Psychiatry;2011, Vol. 11 Issue 1, p21
Background: To compare the efficacy and tolerability of paliperidone extended-release (ER) with risperidone immediate-release using propensity score methodology. Methods: Six double-blind, randomized, placebo-controlled, short-term clinical trials for acute schizophrenia with availability of...
- Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia. Hill, Angela L.; Bin Sun; Karagianis, Jamie L.; Watson, Susan B.; McDonnell, David P. // BMC Psychiatry;2011, Vol. 11 Issue 1, p28
Background: In a recently published 24-week maintenance study of olanzapine long-acting injection (LAI) in schizophrenia (Kane et al., 2010), apparent dose-associated changes were noted in both efficacy and safety parameters. To help clinicians balance safety and efficacy when choosing a dose of...
- Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia. Hill, Angela L.; Bin Sun; Karagianis, Jamie L.; Watson, Susan B.; McDonnell, David P. // BMC Psychiatry;2011, Vol. 11 Issue 1, p28
Background: In a recently published 24-week maintenance study of olanzapine long-acting injection (LAI) in schizophrenia (Kane et al., 2010), apparent dose-associated changes were noted in both efficacy and safety parameters. To help clinicians balance safety and efficacy when choosing a dose of...
- The effect of ethnicity on prescribing practice and treatment outcome in inpatients suffering from schizophrenia in Greece. Douzenis, Athanassios; Apostolopoulos, Athanassios; Seretis, Dionisios; Rizos, Emmanouil N.; Christodoulou, Christos; Lykouras, Lefteris // BMC Psychiatry;2011, Vol. 11 Issue 1, p66
Background: No studies have been conducted in Greece with the aim of investigating the influence of ethnicity on the prescribing and treatment outcome of voluntarily admitted inpatients. Most studies conducted in the UK and the US, both on inpatients and outpatients, focus on the dosage of...
- Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics. Hong Liu-Seifert; Ascher-Svanum, Haya; Osuntokun, Olawale; Kai Yu Jen; Gomez, Juan Carlos // BMC Psychiatry;2011, Vol. 11 Issue 1, p87
Background: When treating schizophrenia, improving patients' productivity level is a major goal considering schizophrenia is a leading cause of functional disability. Productivity level has been identified as the most preferred treatment outcome by patients with schizophrenia. However, little...
- Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients. // BMC Psychiatry;2011, Vol. 11 Issue 1, p124
The article discusses a study by Monia Raffa and colleagues conducted to determine and compare various glutathione levels including total glutathione (GSHt) and reduced glutathione (GSHr), and antioxidant enzyme activities including superoxide dismutase (SOD) and glutathione peroxidase (GPx) in...
- Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study. // BMC Psychiatry;2011, Vol. 11 Issue 1, p143
The article presents a research which attempts at identifying distinct health states among chronically ill patients with schizophrenia who have achieved sustained favorable long-term outcome. It is reported that, the researchers used data from the U.S. Schizophrenia Care and Assessment Program...
- Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia. // BMC Psychiatry;2011, Vol. 11 Issue 1, p152
The article presents a research which examines whether early response predicted later response when using a long-acting injection (LAI) antipsychotic drug named olanzapine for the treatment of schizophrenia. It is reported that, the researchers carried out randomized, double-blind clinical trial...
